XML 20 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating activities:    
Net income $ 26,363 $ 27,749
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation of premises and equipment, and amortization 1,550 1,508
Amortization of intangible assets 514 1,030
Provision for credit losses 3,728 4,015
Amortization of investment securities premium, net 402 6
Loss on sale of investment securities 1,146 0
Originations of loans for resale (15,348) (10,858)
Proceeds from sale of loans originated for resale 14,245 10,151
Gain on sale of loans (344) (261)
Change in fair market value of mortgage servicing rights 140 (11)
Provision for losses on foreclosed assets 0 262
Gain on transfer of loans to foreclosed assets 0 (38)
Loss (gain) on sale of foreclosed assets (3) 0
Operating lease expense payments (1,509) (1,568)
Loss on disposal of fixed assets 85 5
Increase in cash value of life insurance (820) (803)
Gain on life insurance death benefit (1,207) 0
Loss (gain) on marketable and trading equity securities (39) 28
Equity compensation vesting expense 1,139 1,198
Change in:    
Interest receivable 2,274 985
Interest payable (1,816) 1,779
Amortization of operating lease ROUA 1,452 1,499
Other assets and liabilities, net (7,438) (11,596)
Net cash from operating activities 24,514 25,080
Investing activities:    
Proceeds from maturities of securities available for sale 66,753 62,770
Proceeds from maturities of securities held to maturity 4,954 5,625
Proceeds from sale of available for sale securities 30,008 0
Purchases of securities available for sale (14,358) 0
Loan origination and principal collections, net (51,857) (7,379)
Proceeds from sale of other real estate owned 103 0
Purchases of premises and equipment (1,687) (1,028)
Net cash from investing activities 33,916 59,988
Financing activities:    
Net change in deposits 117,756 153,620
Net change in other borrowings 2,096 (240,173)
Repurchase of common stock, net of option exercises (4,109) (3,408)
Dividends paid (10,879) (10,972)
Net cash from (used by) financing activities 104,864 (100,933)
Net change in cash and cash equivalents 163,294 (15,865)
Cash and cash equivalents, beginning of period 144,956 98,701
Cash and cash equivalents, end of period 308,250 82,836
Supplemental disclosure of noncash activities:    
Unrealized gain (loss) on securities available for sale 31,372 (15,898)
Market value of shares tendered in-lieu of cash to pay for exercise of equity and/or related taxes (439) 0
Obligations incurred in conjunction with leased assets 471 1,327
Life insurance receivable 7,582 0
Loans transferred to foreclosed assets 0 12
Supplemental disclosure of cash flow activity:    
Cash paid for interest expense $ 33,351 $ 30,902